- Loblaw reported a total revenue of $15.27 billion in the second quarter, up 4.1 per cent from the same period last year.
- Profit available to common shareholders jumped about five per cent to $751 million.
- Loblaw says sales are up 40 per cent year-to-date.
- Loblaw's discount stores outperformed as consumers hunt for deals, reflecting continued consumer demand for value.
- During the quarter, Loblaw opened a total of 14 stores, including seven hard discount stores, three drug stores, and the first T&T location in California.
- Food retail sales grew 3.3 per cent to $10.6 billion, attributed to higher customer traffic and basket size, as well as e-commerce sales growth.
- Drug retail sales were up 6.1 per cent to $4.43 billion, driven by strength in specialty and chronic prescriptions, as well as beauty and over-the-counter categories.
Loblaw Companies Limited reported a 4.1% revenue increase to $15.27 billion in Q2, driven by strong performance in discount stores like No Frills and Maxi. The company’s net earnings rose 5.2% to $751 million, reflecting increased customer traffic and basket size.124
The grocery giant's discount banners outperformed conventional stores, with comparable sales growth of nearly 4%. Chief Financial Officer Richard Dufresne noted that the retailer continued to gain share in hard discount, driven by sustained consumer demand for value and greater access to discount stores.
Food retail sales grew 3.3% to $10.6 billion, attributed to higher customer traffic and e-commerce sales growth. Drug retail sales increased 6.1% to $4.43 billion, bolstered by strength in specialty and chronic prescriptions, as well as beauty and over-the-counter categories.67
During the quarter, Loblaw opened a total of 14 stores, including seven hard discount stores, three drug stores, and the first T&T location in California. The company continues to focus on discount store expansions as consumers seek more value for their money.5
“Lower generic drug pricing is being offset by higher volumes, and we expect higher revenue, higher gross profit dollars and higher gross margin rate,” Dufresne told analysts during a conference call.
Overall, Loblaw's performance reflects a strategic shift towards discount retailing, catering to a growing consumer base looking for value amidst economic pressures.
“Loblaw's profit available to common shareholders increased by about five per cent to $751 million, reflecting strong customer demand for value at its discount chains. The company also reported a 6.1 per cent rise in drug retail sales to $4.43 billion, driven by growth in specialty and chronic prescriptions.”
